Document Type

Editorial

Publication Date

8-13-2024

Abstract

"In this issue of the Journal, Maghsoudi and colleagues (pp. 82–96) report a series of studies that delineate the biochemical and pharmacological mechanism of this resistance (4). The study focuses on adenylyl cyclase (AC), an enzyme crucial for pulmonary vasodilation through its action of synthesizing cAMP. There are nine isoforms of AC (AC1–AC9) that are all stimulated by Gs but otherwise are distinct in their regulatory qualities, subcellular localization, and expression profiles throughout the body (5). AC6 plays a significant role in fetal and neonatal lung, especially in pulmonary artery smooth muscle cells, where it is highly expressed. This isoform is characterized by its susceptibility to inhibition by a number of other signaling pathways, including calcium, protein kinase A, protein kinase C, and nitric oxide (NO) (6). AC6 is efficiently regulated by several G protein–coupled receptors by virtue of its colocalization in lipid raft microdomains of the plasma membrane of many cells (7)."

Comments

This editorial was originally published in American Journal of Respiratory Cell and Molecular Biology, volume 72, issue 1, in 2024. https://doi.org/10.1165/rcmb.2024-0350ED

Copyright

American Thoracic Society

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.